Related content

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors

By Prince H Miles   Bishton Mark J   Johnstone Ricky W  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 601-612

Future Medicine

Access to resources Recommend Favorite

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)

By Fortunati N.   Catalano M.   Marano F.   Mugoni V.   Pugliese M.   Bosco O.   Mainini F.   Boccuzzi G.  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 667-675

Springer Publishing Company

Access to resources Recommend Favorite

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

By                      

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 10-16

Spandidos Publications

Access to resources Recommend Favorite

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

By Hainsworth John D.   Infante Jeffrey R.   Spigel David R.   Arrowsmith Edward R.   Boccia Ralph V.   Burris Howard A.  

Cancer Investigation, Vol. 29, Iss. 7, 2011-07 ,pp. : 451-455

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2908-2912

Spandidos Publications

Access to resources Recommend Favorite